Table 3.

Procedural characteristics

	All (n = 27)	GLIMGLIN		P
		Success (n = 13)	Failure (n = 14)
Access
Ipsilateral	23 (85.2)	13 (100)	10 (71.4)	0.04*
Contralateral	4 (14.8)	0 (0.0)	4 (28.6)	0.04*
Size of Gladius MG™
0.014 inch	12 (44.4)	5 (38.5)	7 (50.0)	0.55
0.018 inch	15 (55.6)	8 (61.5)	7 (50.0)	0.55
Wiring time
GLIMGLIN (min)	7.1 ± 6.4	6.2 ± 5.6	7.9 ± 7.2	0.83
Total wiring time (min)	30.5 ± 35.3	6.2 ± 5.6	53.0 ± 36.5	< 0.001*
Wire crossing
Wire crossing success (%)	27 (100)	13 (100)	14 (100)	> 0.99
Conventional wiring success (%)	20 (74.1)	13 (100)	7 (50.0)	0.03*
Number of wires for crossing	1.9 ± 1.1	1.0 ± 0.0	2.7 ± 1.0	< 0.001*
IVUS-guided wiring (%)	7 (25.9)	0 (0.0)	7 (50.0)	0.03*
Distal puncture (%)	2 (7.4)	0 (0.0)	2 (14.3)	0.55
Total procedure time (min)	103.4 ± 35.4	80.2 ± 21.7	125.0 ± 32.1	< 0.001*
Total contrast volume (ml)	51.1 ± 16.7	45.8 ± 13.8	56.0 ± 18.1	0.15
Fluoroscopic time (min)	36.9 ± 21.1	23.6 ± 6.9	49.2 ± 22.4	< 0.001*
Procedural success (%)	27 (100)	13 (100)	14 (100)	> 0.99
Final device
Drug coated balloon	14 (51.9)	5 (38.5)	9 (64.3)	0.19
Bare nitinol stent	3 (11.1)	2 (15.4)	1 (7.1)	0.50
Drug eluting stent	9 (33.3)	6 (46.2)	3 (21.4)	0.18
Interwoven stent	1 (3.7)	0 (0.0)	1 (7.1)	0.34
Pre ABI	0.51 ± 0.14	0.50 ± 0.18	0.53 ± 0.11	0.80
Post ABI	0.82 ± 0.23	0.93 ± 0.20	0.73 ± 0.22	0.02*
Short term outcomes within 30 days
All cause death	0 (0.0)	0 (0.0)	0 (0.0)	> 0.99
Major adverse events	1 (3.7)	0 (0.0)	1 (7.1)	0.36
Major amputation	1 (3.7)	0 (0.0)	1 (7.1)	0.36
Minor amputation	1 (3.7)	1 (7.7)	0 (0.0)	0.28
TLR within 30 days	0 (0.0)	0 (0.0)	0 (0.0)	> 0.99
Rutherford classification at 30 days
0,1	20 (74.1)	9 (69.2)	11 (78.6)	0.59
2,3	1 (3.7)	0 (0.0)	1 (7.1)	0.34
4	0 (0.0)	0 (0.0)	0 (0.0)	> 0.99
5,6	6 (22.2)	4 (30.8)	2 (14.3)	0.31

^*P < 0.05, Values are expressed as mean ± standard deviation or number (percentage)